HAWKHILL THERAPEUTICS Ltd
Amendment
CIK: 0002140690·Biotechnology·UNITED KINGDOM·Filed: Sep 28, 2026
Total Offering
$290,530
Amount Sold
$290,530
Investors
1
First Sale
Apr 7, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Limited Liability Company
- Year Incorporated
- 2025
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Christopher Andrew Woodland | Related Person |
| Antoine Boulanger | Related Person |
| Mary Canning | Related Person |
| Francisca Peixoto | Related Person |
| Timothy Jason Sparey | Related Person |
Company
SEC Filing
0002140690-26-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free